Risk factors associated with venous thromboembolism in 49,028 mastectomy patients

Breast

Volumn 22, Issue 4, 2013, Pages 444-448

  Tran, Brian H ^a   JoAnna Nguyen, T ^a   Hwang, Brian H ^a   Vidar, Evan N ^a   Davis, Gabrielle B ^a   Chan, Linda S ^a   Woo, Karen ^a   Wong, Alex K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breast; Breast cancer; Deep venous thrombosis; Mastectomy; NSQIP; Pulmonary embolism; Risk factors; Venous thromboembolism

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; BODY MASS; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RADIOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MASTECTOMY; OBESITY; OPERATION DURATION; PREGNANCY; PRIORITY JOURNAL; RACE; RISK FACTOR; SMOKING; SURGICAL RISK; VEIN CATHETERIZATION; VENOUS THROMBOEMBOLISM;

EID: 84879784052     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.04.018     Document Type: Article

References (34)

1. Heit J.A. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008 Mar, 28(3):370-372.
2. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., Melton L.J. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000 Mar 27, 160(6):809-815.
3. Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAm Med Assoc 2005 Feb 9, 293(6):715-722.
4. Andtbacka R.H., Babiera G., Singletary S.E., Hunt K.K., Meric-Bernstam F., Feig B.W., et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 2006 Jan, 243(1):96-101.
5. Clahsen P.C., van de Velde C.J., Julien J.P., Floiras J.L., Mignolet F.Y. Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European organization for research and treatment of cancer breast cancer cooperative group study. JClin Oncol 1994 Jun, 12(6):1266-1271.
6. Fisher B., Costantino J., Redmond C., Poisson R., Bowman D., Couture J., et al. Arandomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. NEngl J Med 1989 Feb 23, 320(8):479-484.
7. Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., Lyman G.H. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007 Nov 15, 110(10):2339-2346.
8. Wedgwood K.R., Benson E.A. Non-tumour morbidity and mortality after modified radical mastectomy. Ann R Coll Surg Engl 1992 Sep, 74(5):314-317.
9. Hirsh J., Guyatt G., Albers G.W., Harrington R., Schunemann H.J., American College of Chest Physicians Executive summary: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008 Jun, 133(6 Suppl.):71S-109S.
10. Pannucci C.J., Oppenheimer A.J., Wilkins E.G. Practice patterns in venous thromboembolism prophylaxis: a survey of 606 reconstructive breast surgeons. Ann Plast Surg 2010 Jun, 64(6):732-737.
11. Donati M.B. Cancer and thrombosis. Haemostasis 1994 Mar-Apr, 24(2):128-131.
12. Lindner D.J., Edwards J.M., Phinney E.S., Taylor L.M., Porter J.M. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. JVasc Surg 1986 Nov, 4(5):436-442.
13. Strandness D.E., Langlois Y., Cramer M., Randlett A., Thiele B.L. Long-term sequelae of acute venous thrombosis. JAm Med Assoc 1983 Sep 9, 250(10):1289-1292.
14. Patiar S., Kirwan C.C., McDowell G., Bundred N.J., McCollum C.N., Byrne G.J. Prevention of venous thromboembolism in surgical patients with breast cancer. Br J Surg 2007 Apr, 94(4):412-420.
15. Caine G.J., Stonelake P.S., Rea D., Lip G.Y. Coagulopathic complications in breast cancer. Cancer 2003 Oct 15, 98(8):1578-1586.
16. Gibbs J., Clark K., Khuri S., Henderson W., Hur K., Daley J. Validating risk-adjusted surgical outcomes: chart review of process of care. Int J Qual Health Care 2001 Jun, 13(3):187-196.
17. Daley J., Forbes M.G., Young G.J., Charns M.P., Gibbs J.O., Hur K., et al. Validating risk-adjusted surgical outcomes: site visit assessment of process and structure. National VA surgical risk study. JAm Coll Surg 1997 Oct, 185(4):341-351.
18. Surgical case inclusion/exclusion overview [homepage on the Internet]. Chicago: American College of Surgeons. Available from: http://www.acsnsqip.org/main/programspecs/program_case_inclusion_exclusion.jsp.
19. Arkel Y.S. Thrombosis and cancer. Semin Oncol 2000 Jun, 27(3):362-374.
20. Elting L.S., Escalante C.P., Cooksley C., Avritscher E.B., Kurtin D., Hamblin L., et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 2004 Aug 9-23, 164(15):1653-1661.
21. Blom J.W., Vanderschoot J.P., Oostindier M.J., Osanto S., van der Meer F.J., Rosendaal F.R. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. JThromb Haemost 2006 Mar, 4(3):529-535.
22. Sorensen H.T., Mellemkjaer L., Steffensen F.H., Olsen J.H., Nielsen G.L. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. NEngl J Med 1998 Apr 23, 338(17):1169-1173.
23. Hunt K.K., Newman L.A., Copeland E.M., Bland K.I. Chapter 17. The breast. Schwartz's principles of surgery, 9e 2010, The McGraw-Hill Companies, New York. 9th ed. F.C. Brunicardi, D.K. Andersen, T.R. Billiar, D.L. Dunn, J.G. Hunter, J.B. Matthews (Eds.).
24. Liem T.K., Moneta G.L. Chapter 24. Venous and lymphatic disease. Schwartz's principles of surgery, 9e 2010, The McGraw-Hill Companies, New York. 9th ed. F.C. Brunicardi, D.K. Andersen, T.R. Billiar, D.L. Dunn, J.G. Hunter, J.B. Matthews (Eds.).
25. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. NEngl J Med 1989 Feb 23, 320(8):491-496. Ludwig Breast Cancer Study Group.
26. Goldhaber S.Z. Chapter 256. Deep venous thrombosis and pulmonary thromboembolism. Harrison's principles of internal medicine 2008, The McGraw-Hill Companies, New York. 17th ed. A.S. Fauci, E. Braunwald, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L. Jameson (Eds.).
27. Stein P.D., Hull R.D., Matta F., Yaekoub A.Y., Liang J. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am J Med 2009 Oct, 122(10):919-930.
28. Eichinger S., Hron G., Bialonczyk C., Hirschl M., Minar E., Wagner O., et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 2008 Aug 11, 168(15):1678-1683.
29. Willenberg T., Schumacher A., Amann-Vesti B., Jacomella V., Thalhammer C., Diehm N., et al. Impact of obesity on venous hemodynamics of the lower limbs. JVasc Surg 2010 Sep, 52(3):664-668.
30. Cronenwett J.L., Johnston W. Chapter 48: risk factors. Rutherford's vascular surgery 2010, Elsevier Inc., Philadelphia. 7th ed. R. Cambria (Ed.).
31. Bozzetti F., Scarpa D., Terno G., Scotti A., Ammatuna M., Bonalumi M.G., et al. Subclavian venous thrombosis due to indwelling catheters: a prospective study on 52 patients. JPEN J Parenter Enteral Nutr 1983 Nov-Dec, 7(6):560-562.
32. Falanga A., Ofosu F.A., Cortelazzo S., Delaini F., Consonni R., Caccia R., et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Br J Haematol 1993 Dec, 85(4):745-750.
33. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., et al. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008 Jun, 133(6 Suppl.):381S-453S.
34. Hall I.E., Andersen M.S., Krumholz H.M., Gross C.P. Predictors of venous thromboembolism in patients with advanced common solid cancers. JCancer Epidemiol 2009, 2009:182521.